Stockreport

Relmada Therapeutics: Run Up Into Results May Resume Following This Drop [Seeking Alpha]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF The current timeline for completion of enrolment in Reliance II may suggest a slight slippage, but my position on the potential for a run up is unchanged. RLMD notes [Read more]